Search
Search through the thousands of lawsuits, complaints and recalls on our site.

Synovis Life Technologies Misled Investing Public

Report Fraud
Case ID: 3504 | Stocks | 10/13/2005

Several class actions have been filed against medical device company Synovis Life Technologies, Inc., (Nasdaq:SYNO) and certain of its officers and directors by stockholders who purchased the company's common stock between October 16, 2003, and May 18, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.

The action alleges that the defendants concealed the following facts from the investing public:

• Synovis’ surgical business was not on track for year-to-year growth and was actually declining;
• The company's Peri-Strips were losing market share to a competing device made by Gore-Medical;
• The defendants misled the public as to why Peri-Strips sales fell short, claiming that the number of surgeons qualified to perform procedures had declined, taking sales down as well;
• The company's "interventional" side had little to zero growth prospects.

As a result, the company's projections of fiscal 2004 EPS of $.56-$.60 and revenues of $75-$79 million were false and misleading.

On May 19, 2004, Synovis drastically cut its guidance for fiscal 2004 in a press release which stated: "At the halfway point of the year, we have fallen behind our own expectations and have clearly not met the expectations of the market....While the interventional business showed significant sequential improvement during the second quarter, it is not yet back to fiscal 2003 levels. In the surgical business, several factors affecting the gastric bypass market evolved during the second quarter, constraining recent Peri-Strips sales growth and near-term growth prospects for Peri-Strips use in gastric bypass surgery. The magnitude of the revenue shortfall in the interventional business, combined with changes in the gastric bypass market, significantly reduce the likelihood of the strong year-over-year growth we expected in fiscal 2004."

On this news, Synovis stock fell from a close of $14.65 on May 18, 2004, to a close of $9.25 on May 19, 2004, for a single-day decline of more than 36% on very heavy trading volume.

If you purchased securities issued by Synovis Life Technologies during the applicable period, you may request appointment by the court as a lead plaintiff if you do so by August 16, 2004. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the court must determine that your claim is typical of the claims of other class members, and that you will adequately represent the class. Under certain circumstances, one or more class members may together serve as lead plaintiffs. Your ability to share in any recovery is not affected by the decision whether or not to serve as a lead plaintiff. You may retain any counsel of your choice to serve as you in this action, or you may choose to do nothing, and remain in the class as a silent member.


At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints.

Other Stocks Cases of Interest

Kahn Gauthier Swick, LLC ("KGS") announces that shareholders of Radian Group Inc. (“Radian” or the “Company”) (NYSE:RDN - News) who purchased securities of the Company between January 23, 2007 and July 31, 2007 (the "Class Period"), have until October 15, 2007 to move for appointment as Lead Plaintiff in a securities class action lawsuit currently pending in the United States District Court for the Eastern District of Pennsylvania. No class has yet been certified in this action.
 
According to a law firm press release, a complaint filed June 11, 2008 alleges that during the Class Period, defendants issued materially false and misleading statements regarding the Company's business and financial results. Specifically, defendants downplayed and concealed IndyMac's growing exposure to non-performing assets, particularly loans in its pay-option adjustable-rate mortgage ("Option ARM") and homebuilder construction portfolios, and made numerous positive representations regarding the Company's capital position to alleviate investors' fears concerning the Company's capital erosion. As a result of defendants' false statements, IndyMac stock traded at artificially inflated prices during the Class Period, reaching a Class Period high of $24.55 per share in October 2007.
 
The court has rendered a $10 million judgment against Canadian company Danier Leather, Inc., (Toronto:DL.TO) in favor of investors who purchased the company’s common stock pursuant to the its May 1998 IPO. The action alleged that the defendants intentionally misled the investing public with an inaccurate prospectus, when it predicted it would have $17.4-million in fourth-quarter revenue and a $384,000 loss in fiscal year 1998. Persons eligible to take part in the action should contact attorneys for the class as soon as possible.
 
Many company retirement plans that encouraged investment in the company stock plan have taken large losses over the past few years. A class action has been filed against TV-top cablebox manufacturer Scientific-Atlanta, Inc. and certain company officials on behalf of current and former employees whose retirement plans were invested in the company's stock. The action alleges that the executives breached their fiduciary responsibilities in violation of federal labor law when they knew of the company's financial problems but continued to encourage employees to purchase stock for their plans, sometimes while selling their own shares. The action seeks compensatory and punitive damages.
 
On April 7, 2008, the case was transferred from the Supreme Court of the State of New York to the U.S. District Court for the Eastern District of New York.
 
A class action has been filed against online sports information provider Sportsline.com Inc. (Nasdaq: SPLN) and certain of its officers and directors by stockholders who purchased the company's common stock between May 15, 2001, and September 25, 2003.
 
Become a LawCash Member - FREE!
'Find Money' E-Book
Weekly Email Alerts




privacy policy
YouNewz Beta
IT'S FREE

Report

Report Newz and easily upload your own newzworthy photos from your cell phone or computer to the web.

Share

Quickly share your photos with family, friends, co-workers, or the world with your own Newzpaper.

Read

Instantly find Newz and photos from other YouNewzers and read other YouNewzers Newzpapers.
 
Class Action Lawsuit Center || Product Recall Center || Consumer Complaint Center || About LawCash Link Exchange
Privacy Policy || Legal Policies || Terms & Conditions || Website Advertising Policy || Site Map || Top Lawsuits
LawCash® is a service of nola3, llc
© 2000 - 2008 Copyright. All rights reserved nola3, llc.

[ Home ]
LawCash
login
Justice is a click away.